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The Ikaros family of zinc-ﬁnger proteins
Yingzhi Fan, Duo Lu
State Key Laboratory of Bioactive Substances and Function of Natural Medicine,
Institute of Materia Medica, Chinese Academy of Medical Sciences, Beijing 100050, ChinaIkaros is a large zinc-ﬁnger protein family important for lymphocyte development and certain other
physiological processes. In this review, existing knowledge as to the functions, regulatory pathways, and
molecular mechanisms of this family of proteins is collected in order to gain a better understanding through
comparison of activities and interactions among family members.
Acta Pharmaceutica Sinica B, 6 (2016) 522The fate of medications evaluated for ischemic stroke pharmacotherapy over the period 1995–2015
Xiaoling Chena, Kewei Wanga,b
aDepartment of Molecular and Cellular Pharmacology, State Key Laboratory of Natural and
Biomimetic Drugs, Peking University School of Pharmaceutical Sciences, Beijing 100191, China
bDepartment of Pharmacology, Qingdao University School of Pharmacy, Qingdao 266021, ChinaThe fate of 430 drugs evaluated in treating ischemic stroke over the period 1995–2015 are is analyzed. Only 4% of
them, classiﬁed as thrombolytics and neuroprotective agents, successfully reached the market whereas all N-methyl-D-
aspartate (NMDA) receptor antagonists failed in clinical trials. This analysis reveals that targeting non-NMDA-
mediated calcium overload may be a promising strategy for improving the pharmacotherapy of ischemic stroke.Acta Pharmaceutica Sinica B, 6 (2016) 531
MicroRNAs in idiopathic pulmonary ﬁbrosis: involvement in pathogenesis and
potential use in diagnosis and therapeutics
Huimin Li, Xiaoguang Zhao, Hongli Shan, Haihai Liang
Department of Pharmacology, College of Pharmacy, Harbin Medical University,
Harbin 150081, ChinaMicroRNAs (miRNAs) have been found to participate in cell proliferation, differentiation and apoptosis. Some
miRNAs have been reported to be involved in the pathogenesis of pulmonary ﬁbrosis. In this review, we
discuss the role of miRNAs in the pathogenesis, diagnosis and treatment of idiopathic pulmonary ﬁbrosis.
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New techniques of on-line biological sample processing and their application in the ﬁeld of biopharmaceutical analysisJie Penga, Fang Tanga, Rui Zhoua, Xiang Xiea, Sanwang Lia, Feifan Xiea, Peng Yua, Lingli Mub
aSchool of Pharmaceutical Sciences, Central South University, Changsha 410013, China
bMedical College, Hunan Normal University, Changsha 410006, ChinaThis paper summarizes several new techniques of on-line biological samples processing in recent years
(such as solid phase extraction, solid phase micro-extraction, column switching technique, limit intake ﬁller
technique, molecular imprinted solid phase extraction technique, tubular column technique and micro-
dialysis technique), and describes their developments, principles, characteristics and application matched
with liquid chromatography–mass spectrometry (LC–MS) in biopharmaceutical analysis in on-line
biological sample processing ﬁeld.
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A review of global initiatives to ﬁght antibiotic resistance and recent antibiotics' discovery
Arpana Sagwal Chaudhary
Intellectual Property Consultant, Life Sciences, CA 94597, USAOriginal Articles
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A high-throughput screening assay for eukaryotic elongation factor 2 kinase inhibitors
Ting Xiaoa,b, Rui Liuc,d, Christopher G. Proudc,d, Ming-Wei Wanga
aThe National Center for Drug Screening and the CAS Key Laboratory of Receptor Research,
Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China
bDepartment of Pharmacy, Medical College of Nanchang University, Nanchang 330066, China
cCenter for Biological Sciences, Life Sciences Building, University of Southampton, Southampton
SO16 7LB, UK
dSouth Australian Health and Medical Research Institute, North Terrace, Adelaide SA5000,
AustraliaIn this paper, we describe a luminescence-based high-throughput screening (HTS) assay for eukaryotic
elongation factor 2 kinase (eEF2K) which represents a potential target for anti-cancer agents. Our HTS
campaign against 56,000 small molecule compounds identiﬁed 9 initial hits which were further studied in
cancer cell lines.Acta Pharmaceutica Sinica B, 6 (2016) 564
Two new phenylpropanoid glycosides from the aerial parts of Lespedeza cuneata
Chuangfeng Zhanga, Jian Zhoua,b, Jingzhi Yanga, Chuangjun Lia, Jie Maa, Dan Zhanga,
Dongming Zhanga
aState Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute
of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College,
Beijing 100050, China
bDepartment of Pharmacy, The First Afﬁliated Hospital of Nanchang University,
Nanchang 330006, China
Two new phenylpropanoid glycosides, cuneataside E (1) and cuneataside F (2), were isolated from the aerial
parts of Lespedeza cuneate (Dum. Cours.) G. Don, as E and Z isomer, respectively. At the concentration of
10 μmol/L, compound 1 showed moderate hepatoprotective activity against N-acetyl-p-aminophenol (APAP)-
induced toxicity in HepG2 cells.Acta Pharmaceutica Sinica B, 6 (2016) 568
Identiﬁcation and differentiation of Panax ginseng, Panax quinquefolium, and
Panax notoginseng by monitoring multiple diagnostic chemical markers
Wenzhi Yanga,b, Xue Qiaoa, Kai Lia, Jingran Fana, Tao Boc, De-an Guob, Min Yea
aState Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences,
Peking University, Beijing 100191, China
bShanghai Research Center for Modernization of Traditional Chinese Medicine,
National Engineering Laboratory for TCM Standardization Technology, Shanghai Institute
of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China
cAgilent Technologies, Beijing 100102, ChinaThe roots of Panax ginseng (PG), Panax quinquefolium (PQ) and Panax notoginseng (PN) derive from congeneric
species, and are used as different herbal medicines. In this study, we employed LC–MS analyses and chemometric
approaches to discover 17 marker ginsenosides to differentiate these three species. These markers were further used
to identify PG, PQ, and PN in 60 batches of traditional Chinese medicine compound preparations.
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Pharmacokinetics of H002, a novel S1PR1 modulator, and its metabolites in rat
blood using liquid chromatography–tandem mass spectrometry
Jiaqi Mi, Manman Zhao, Shu Yang, Shuang Yang, Jing Jin, Xiaojian Wang,
Qiong Xiao, Jinping Hu, Yan Li
Department of Drug Metabolism, Beijing Key Laboratory of Non-Clinical Drug
Metabolism and PK/PD study, Key Laboratory of Active Substances Discovery
and Drug Ability Evaluation, State Key Laboratory of Bioactive Substance
and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy
of Medical Sciences & Peking Union Medical College, Beijing 100050, ChinaA rapid and sensitive liquid chromatography–tandem mass spectrometry (LC–MS/MS) method
was developed and validated for the simultaneous determination of H002 and its phosphorylated
metabolites, H002-P and hydroxylated metabolite H002-M, in rat blood. The pharmacokinetics
of H002 correlated with its biological effect on peripheral blood lymphocytes.Acta Pharmaceutica Sinica B, 6 (2016) 584
Pharmacokinetic evaluation of Shenfu Injection in beagle dogs after intravenous
drip administration
Yuqiao Zhanga, Dali Tianb, Yuyou Huangb, Ling Lia, Juan Maoa,
Juan Tiana, Jinsong Dinga
aSchool of Pharmaceutical Sciences, Central South University, Changsha 410013, China
bChina Resources San-Jiu (Ya’an) Pharmaceutical Co., Ltd., Ya’an 625000, ChinaShenfu Injection (SFI) is a commonly used traditional Chinese formulation composed of the
extracts of red ginseng and aconite. Two alkaloids (benzoylmesaconine and fuziline) and three
ginsenosides (Rg1, Rb1 and Rc), which are the main active ingredients, were selected as the
indexes to explore the pharmacokinetics of SFI. Based on this, predictable and linear increase of
the systemic exposure of SFI can be expected.
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Simultaneous quantiﬁcation of ginsenoside Rg1 and its metabolites by
HPLC–MS/MS: Rg1 excretion in rat bile, urine and feces
Chiyu Hea, Ru Fenga, Yupeng Suna, Shifeng Chua, Ji Chena, Chao Mab, Jie Fua,
Zhenxiong Zhaoa, Min Huanga, Jiawen Shoua, Xiaoyang Lia, Yuzhu Wanga,
Jinfeng Hua, Yan Wanga, Juntian Zhanga
aState Key Laboratory of Bioactive Substances and Functions of Natural Medicines,
Institute of Materia Medica, Chinese Academy of Medical Sciences, Beijing 100050, China
bBeijing Analytical Application Center, Shimadzu (China) Co., Ltd., Beijing 100020, ChinaThis study describes a sensitive, accurate and simple high performance liquid chromatography–
tandem mass spectrometry (LC–MS/MS) method to simultaneously quantify Rg1 and its
metabolites Rh1 and Ppt in the bile, urine and feces. The present work provides valuable
information for the continued evaluation of Rg1 as a therapeutic agent.
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Effect of hydrogen bond formation/replacement on solubility characteristics,
gastric permeation and pharmacokinetics of curcumin by application of
powder solution technology
Vijay Sharma, Kamla Pathak
Department of Pharmaceutics, Rajiv Academy for Pharmacy,
Delhi - Mathura Road, Mathura 281001, Uttar Pradesh, IndiaA liquisolid tablet of curcumin was prepared by compression of a liquisolid system made by
solubilizing curcumin in a non-volatile solvent followed by adsorption/absorption on MCC
PH102 (carrier) and coating with Aerosils(coating material). Increased solubility/release
characteristics of curcumin through formulation in a liquisolid tablet resulted in enhanced
bioavailability in New Zealand rabbits as compared to a conventional directly compressed tablet
of curcumin.
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Cloning and expression of SgCYP450-4 from Siraitia grosvenorii
Dongping Tua, Xiaojun Maa,b, Huan Zhaoa, Changming Moc, Qi Tangd,
Liuping Wange, Jie Huange, Limei Panc
aInstitute of Medicinal Plant Development, Chinese Academy of Medical Sciences
and Peking Union Medical College, Peking 100193, China
bYunnan Branch Institute of Medicinal Plant Development, Chinese Academy of
Medical Sciences, Jinghong 530023, China
cGuangxi Botanical Garden of Medicinal Plants, Nanning 530023, China
dHorticulture & Landscape College, Hunan Agriculture University,
Changsha 410128, China
eGuangxi University of Chinese Medicine, Nanning 530001, ChinaWe cloned a CYP450 gene from Siraitia grosvenorii designated SgCYP450-4. The full-length open reading frame (ORF) of SgCYP450-4 is 1422 bp,
encoding 473 amino acids with a predicted molecular weight of 50.01 kDa and an isoelectric point (IP) of 8.8. The SgCYP450-4 gene is mainly
expressed in root and stem, and the lowest in peel. The expression of SgCYP450-4 could be signiﬁcantly induced by hormone treatment.
Short Communication
Acta Pharmaceutica Sinica B, 6 (2016) 623
Effect of isopropyl myristate on the viscoelasticity and drug release of a
drug-in-adhesive transdermal patch containing blonanserin
Chunyi Zhao, Peng Quan, Chao Liu, Qiaoyun Li, Liang Fang
Department of Pharmaceutics, Shenyang Pharmaceutical University, Shenyang 110016, China
Isopropyl myristate (IPM), a commonly used penetration enhancer, can act as a plasticizer on
Duro-TAKs 87-2287. The plasticization effect caused an enhancement of drug release, an increase in
the tack and a decrease in the shear-adhesion of the transdermal patch.
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Idiopathic pulmonary ﬁbrosis (IPF) is a chronic, progressive, and highly lethal disease with poor treatment and unknown etiology. Increasing evidences have
been demonstrated that microRNAs (miRNAs) play pivotal roles in the initiation and progression of IPF. First, many miRNAs have been reported to
participate in various steps of IPF, including modulation of inﬂammatory response, suppression of myoﬁbroblasts foci formation and inhibition of extra-
cellular matrix deposition. Second, more than 80% of dysregulated miRNAs are down-regulated in IPF patients and dysregulated miRNAs present in
inherent mutual regulationship, which forms a complex IPF-related network. However, the reason that causes the global down-regulation of miRNAs in IPF
is still unknown. Third, miRNAs have the potential to be effective biomarkers for the early diagnosis and prevention of pulmonary ﬁbrosis. Finally, miRNAs
might be a novel weapon against IPF. Understanding the impact of dysregulated miRNAs on IPF progression can expand new sights for the discovery of IPF
therapeutic strategy. We believe that miRNAs is the dawn of IPF, even though currently some difﬁculties are encountered in the basic and translational
research of miRNAs.
Haihai Liang
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Panax ginseng C. A. Meyer, P. quinquefolium L., and P. notoginseng are botanical sources for the popular traditional Chinese medicines Ren-Shen, Xi-
Yang-Shen, and San-Qi, respectively. They are also the component herbs for numerous important traditional Chinese patent medicines (TCPMs). Although
the three Panax species contain similar ginsenosides, their properties and functions vary remarkably according to the TCM theory. A number of methods
have been established to distinguish the three species in the form of crude drugs. However, simple and effective approaches are still lacking to identify the
Panax species in complicated TCPMs. This research article by Yang and colleagues presented an LC–MS–based multi-markers monitoring approach, and
proved that the chemical markers deduced from pattern recognition chemometric analysis could be used to accurately identify the Panax species in
commercial TCPMs. Moreover, ginsenoside Rs1 was found to be a new marker to differentiate P. quinquefolium and P. ginseng
.
Min Ye
